Our findings align with a previous report showing that chronic interleukin-1 exposure selects for CEBPA-knockout HSPCs69, collectively supporting the idea that chronic inflammatory conditions may favor the outgrowth of CEBPA-mutant clones, as observed with other common AML mutations52–55,59,83,84. The gene discussed is CEBPA; the disease is acute myeloid leukemia.